Previous 10 | Next 10 |
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company leveraging its proprietary hyaluronic acid ("HA") technology platform to provide therapies across the Joint Preservation and Restoration continuum of care, today announced it has commenced the U.S. ...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you can r...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Noteworthy events during the week of September 15 - 21 for healthcare investors. More news on: CRISPR Therapeutics AG, Pluristem Therapeutics Inc., GlaxoSmithKline plc, Healthcare stocks news, , Read more ...
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced that it will host an Analyst and Investor Day on Wednesday, September 18, 2019 from 9:00 a.m...
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced that Joseph Darling, President and Chief Executive Officer, and Sylvia Cheun...
Company to Deploy Hybrid Commercial Strategy to Support U.S.Sales and Distribution Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , t...
Quick Take InMode ( INMD ) has filed to raise gross proceeds of $75 million from a U.S. IPO, according to an F-1/A registration statement . The firm provides minimally-invasive surgical aesthetic and medical treatment solutions for physicians. INMD is growing smartly, is profitable and ...
Here are four stocks to watch according to Harry Boxer . Three of them moving on strong earnings. Anika Therapeutics, Inc. ( ANIK ) popped $11.78, or 28.8%, to $52.60 on Thursday on 1.3 million shares, or about 8x its average volume. The small biotech beat analyst estimates in its...
Gainers : Anika Therapeutics (NASDAQ: ANIK ) +34% . TCR2 Therapeutics (NASDAQ: TCRR ) +30% . Diebold Nixdorf (NYSE: DBD ) +26% . EDAP TMS (NASDAQ: EDAP ) +20% . Hovnanian (NYSE: HOV ) +18%. NETGEAR (NASDAQ: NTGR ) +16% . Meritage Homes (NYSE: MTH ) +16% . Empire Resorts (NASDA...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...